SNY presents additional Lemtrada data from CARE-MS I trial: http://finance.yahoo.com/news/Alemtuzumab-Lemtrada-bw-4094658172.html?x=0&.v=1 Lemtrada is the (proposed) brand name for Campath when the drug is used in MS.